Overview
Dr. Gregory is the Margaret Harris and David Silverman Distinguished Professor and Director of the Brain Tumor Omics Program in the Duke Department of Neurosurgery, the Vice Chair of Research in the Department of Neurology, and Director of the Molecular Genomics Core at the Duke Molecular Physiology Institute.
As a neurogenomicist, Dr. Gregory applies the experience gained from leading the sequencing of chromosome 1 for the Human Genome Project to elucidating the mechanisms underlying multi-factorial diseases using genetic, genomic, and epigenetic approaches. Dr. Gregory’s primary areas of research involve understanding the molecular processes associated with disease development and progression in brain tumors and Alzheimer’s disease, drug induced white matter injury repair in multiple sclerosis, and the characterization of lesion microenvironmental changes in MS.
He is broadly regarded across Duke as a leader in the development of novel single cell and spatial molecular technologies towards understanding the pathogenic mechanisms of disease development. Dr. Gregory is also the Section Chair of Genomics and Epigenetics at the DMPI and Director of the Duke Center of Autoimmunity and MS in the Department of Neurology.
Current Appointments & Affiliations
Recent Publications
Serum metabolomic signatures of relapse recovery in early multiple sclerosis.
Journal Article Mult Scler Relat Disord · April 2026 BACKGROUND: Relapses in relapsing-remitting multiple sclerosis (RRMS) are acute neuroinflammatory events that shape long-term disease trajectory. Yet, the molecular events during the early recovery period remain poorly characterized, particularly in early, ... Full text Link to item CiteLymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration.
Journal Article Cancer Immunol Res · February 3, 2026 Tumor-draining lymph nodes are a pivotal site for antitumor T-cell priming. However, their mechanistic roles in cancer immune surveillance and immunotherapy response remain poorly defined. Intratumor (IT) virotherapy generates antitumor T-cell immunity thr ... Full text Link to item CiteSupplementary Figure S5 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration
Other · February 3, 2026 <p>Supplementary Figure S5. PVSRIPO is shed in phosphatidyl-serine enriched vesicles from A375 melanoma cells (extended data relating to Figure 4G).</p> ... Full text CiteRecent Grants
BCG-Mediated Immunotherapy Against Bacteria
ResearchCo Investigator · Awarded by National Institutes of Health · 2026 - 2031Pathogenic Mechanisms of Inflammatory Subventricular Zone Injury in Preterm Infants
ResearchCo Investigator · Awarded by National Institutes of Health · 2025 - 2030McCain/Bayh Glioblastoma Consortium
Clinical TrialCo Investigator · Awarded by Department of Defense · 2025 - 2029View All Grants